Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

10.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.0K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

3.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

38.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

5.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NSAIDs for PI3K-altered head and neck cancer: a biomarker-driven therapeutic opportunity.

Cancer biology & medicine·2026
Same author

Metastatic Lymph Node Status Is Associated With Progression-Free Survival in Oral Cavity Squamous Cell Carcinoma Treated With Pembrolizumab.

Head & neck·2026
Same author

Economic Impact of a Deep Learning Algorithm for Automated Head and Neck Surgery Referral Triage.

The Laryngoscope·2026
Same author

Constitutively active MEK1 expression driven by the myeloid-selective MRP8 promoter induces epithelial hyperplasia and papilloma formation.

Biochemical and biophysical research communications·2026
Same author

Potent Anti-Tumor Activity of the AXL-Targeted Antibody-Drug Conjugate, Mipasetamab Uzoptirine (ADCT-601), in Preclinical Models of Adenoid Cystic Carcinoma.

Molecular cancer therapeutics·2026
Same author

Changes in Time to Diagnosis of HPV<sup>+</sup> Oropharyngeal Squamous Cell Carcinoma.

Head & neck·2026

Related Experiment Video

Updated: Jan 12, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.1K

Human Papilloma Virus Does Not Fully Inactivate p53 Cellular Activity in HNSCC.

Jovanka Gencel-Augusto1,2, Hua Li1,2, Liam C Woerner1,2

  • 1Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco (UCSF), San Francisco, California, USA.

Head & Neck
|October 31, 2025
PubMed
Summary
This summary is machine-generated.

Head and neck squamous cell carcinoma (HNSCC) with wild-type TP53 and human papillomavirus (HPV+) shows residual p53 activity, improving patient survival. Loss of this p53 function in HPV+ HNSCC promotes tumor growth and suggests new therapeutic targets.

Keywords:
HNSCCHPVPI3Kp53tumor suppression

More Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
12:09

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

19
Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

10.0K

Related Experiment Videos

Last Updated: Jan 12, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.1K
Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
12:09

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

19
Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

10.0K

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Head and neck squamous cell carcinoma (HNSCC) is a significant global health concern.
  • Tumor suppressor p53 inactivation is a frequent event in HNSCC, occurring via TP53 mutations or human papillomavirus (HPV)-mediated degradation.
  • HPV-positive (HPV+) HNSCC generally has better outcomes than HPV-negative HNSCC, but a subset of HPV+ tumors harbor TP53 mutations.

Purpose of the Study:

  • To investigate the role and extent of p53 activity in HPV+ HNSCC, particularly in tumors with wild-type (WT) TP53.
  • To explore the functional consequences of p53 loss in HPV+ HNSCC.
  • To identify potential therapeutic vulnerabilities associated with p53 status in HPV+ HNSCC.

Main Methods:

  • Analysis of clinical outcomes based on HPV and TP53 mutation status.
  • In vitro experiments assessing proliferation, migration, and invasion of HPV+ HNSCC cells with varying p53 status.
  • Transcriptomic analysis to identify p53-dependent gene regulation.
  • Assessment of genomic alterations and signaling pathway activity (e.g., PI3K-AKT).

Main Results:

  • HPV+ TP53-WT HNSCC cells exhibit residual tumor suppressive p53 activity.
  • Patients with HPV+ TP53-WT tumors show significantly better survival compared to those with HPV+ TP53-mutant or HPV-negative tumors.
  • Loss of WT p53 in HPV+ HNSCC enhances tumor cell proliferation, migration, and invasion, alters methylation patterns, increases chromosomal instability, and impacts PI3K-AKT signaling.

Conclusions:

  • p53 is not completely inactivated in all HPV+ HNSCC, with residual tumor suppressive functions present in WT cases.
  • p53 loss in HPV+ HNSCC contributes to aggressive tumor behavior and altered signaling pathways, including PI3K-AKT.
  • TP53 status may be a valuable biomarker for stratifying HPV+ HNSCC patients and identifying novel therapeutic targets, such as PI3K pathway inhibition.